Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management

G Rogler, A Singh, A Kavanaugh, DT Rubin - Gastroenterology, 2021 - Elsevier
Inflammatory bowel diseases (IBDs) are systemic diseases that manifest not only in the gut
and gastrointestinal tract, but also in the extraintestinal organs in many patients. The quality …

[PDF][PDF] Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations …

F Magro, P Gionchetti, R Eliakim… - Journal of Crohn's …, 2017 - academic.oup.com
1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes
continuous mucosal inflammation of the colon, usually without granulomas on biopsy. It …

ACG clinical guideline: ulcerative colitis in adults

DT Rubin, AN Ananthakrishnan… - Official journal of the …, 2019 - journals.lww.com
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the
preferred approach to the management of adults with UC and represent the official practice …

ACG clinical guideline: management of Crohn's disease in adults

GR Lichtenstein, EV Loftus, KL Isaacs… - Official journal of the …, 2018 - journals.lww.com
Crohn's disease is an idiopathic inflammatory disorder of unknown etiology with genetic,
immunologic, and environmental influences. The incidence of Crohn's disease has steadily …

Environmental triggers in IBD: a review of progress and evidence

AN Ananthakrishnan, CN Bernstein… - Nature reviews …, 2018 - nature.com
A number of environmental factors have been associated with the development of IBD.
Alteration of the gut microbiota, or dysbiosis, is closely linked to initiation or progression of …

[PDF][PDF] Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review

R Sohail, M Mathew, KK Patel, SA Reddy, Z Haider… - Cureus, 2023 - cureus.com
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for their anti-
inflammatory, antipyretic, and analgesic properties. However, their use is often associated …

[PDF][PDF] Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management

M Harbord, R Eliakim, D Bettenworth… - Journal of Crohn's …, 2017 - academic.oup.com
11.1. General The treatment strategy for ulcerative colitis [UC] is mainly based on the
severity, distribution [proctitis, left-sided, extensive] 1 and pattern of disease. The latter …

Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs

I Bjarnason, C Scarpignato, E Holmgren, M Olszewski… - Gastroenterology, 2018 - Elsevier
Nonsteroidal anti-inflammatory drugs (NSAIDs) can damage the gastrointestinal tract,
causing widespread morbidity and mortality. Although mechanisms of damage involve the …

Extraintestinal manifestations of inflammatory bowel disease

SR Vavricka, A Schoepfer, M Scharl… - Inflammatory bowel …, 2015 - academic.oup.com
Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and
may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with …

The effectiveness of probiotics in the treatment of inflammatory bowel disease (IBD)—a critical review

D Jakubczyk, K Leszczyńska, S Górska - Nutrients, 2020 - mdpi.com
Inflammatory bowel disease (IBD), which affects millions of people worldwide, includes two
separate diseases: Crohn's disease (CD) and ulcerative colitis (UC). Although the …